-
1
-
-
85047691529
-
Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis
-
10.1053/j.soncn.2003.10.002, 15038511
-
Avritscher EB, Cooksley CD, Elting LS. Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Semin Oncol Nurs 2004, 20:3-10. 10.1053/j.soncn.2003.10.002, 15038511.
-
(2004)
Semin Oncol Nurs
, vol.20
, pp. 3-10
-
-
Avritscher, E.B.1
Cooksley, C.D.2
Elting, L.S.3
-
2
-
-
85047693566
-
Gastrointestinal mucositis
-
10.1053/j.soncn.2003.10.007, 15038516
-
Keefe DM, Gibson RJ, Hauer-Jensen M. Gastrointestinal mucositis. Semin Oncol Nurs 2004, 20:38-47. 10.1053/j.soncn.2003.10.007, 15038516.
-
(2004)
Semin Oncol Nurs
, vol.20
, pp. 38-47
-
-
Keefe, D.M.1
Gibson, R.J.2
Hauer-Jensen, M.3
-
3
-
-
33847389418
-
Updated clinical practice guidelines for the prevention and treatment of mucositis
-
10.1002/cncr.22484, 17236223
-
Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007, 109:820-831. 10.1002/cncr.22484, 17236223.
-
(2007)
Cancer
, vol.109
, pp. 820-831
-
-
Keefe, D.M.1
Schubert, M.M.2
Elting, L.S.3
Sonis, S.T.4
Epstein, J.B.5
Raber-Durlacher, J.E.6
Migliorati, C.A.7
McGuire, D.B.8
Hutchins, R.D.9
Peterson, D.E.10
-
4
-
-
0032419292
-
Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting
-
Pico JL, Avila-Garavito A, Naccache P. Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting. Oncologist 1998, 3:446-451.
-
(1998)
Oncologist
, vol.3
, pp. 446-451
-
-
Pico, J.L.1
Avila-Garavito, A.2
Naccache, P.3
-
5
-
-
1942469964
-
The pathobiology of mucositis
-
10.1038/nrc1318, 15057287
-
Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004, 4:277-284. 10.1038/nrc1318, 15057287.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 277-284
-
-
Sonis, S.T.1
-
6
-
-
42149113491
-
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
-
10.1007/s00280-007-0570-0, 17703303
-
Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 2008, 62(1):33-41. 10.1007/s00280-007-0570-0, 17703303.
-
(2008)
Cancer Chemother Pharmacol
, vol.62
, Issue.1
, pp. 33-41
-
-
Logan, R.M.1
Gibson, R.J.2
Bowen, J.M.3
Stringer, A.M.4
Sonis, S.T.5
Keefe, D.M.6
-
7
-
-
32544458185
-
Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches
-
10.1016/j.etp.2005.09.006, 16414253
-
Cho SA, Park JH, Seok SH, Juhn JH, Kim SJ, Ji HJ, Choo YS, Park JH. Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches. Exp Toxicol Pathol 2006, 57:321-328. 10.1016/j.etp.2005.09.006, 16414253.
-
(2006)
Exp Toxicol Pathol
, vol.57
, pp. 321-328
-
-
Cho, S.A.1
Park, J.H.2
Seok, S.H.3
Juhn, J.H.4
Kim, S.J.5
Ji, H.J.6
Choo, Y.S.7
Park, J.H.8
-
8
-
-
0033918355
-
Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters
-
10.1016/S1368-8375(00)00012-9, 10899677
-
Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, Login G, Ymamkawa M, Moses G, Bouchard P, Hayes LL, Bedrosian C, Dorner AJ. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000, 36:373-381. 10.1016/S1368-8375(00)00012-9, 10899677.
-
(2000)
Oral Oncol
, vol.36
, pp. 373-381
-
-
Sonis, S.T.1
Peterson, R.L.2
Edwards, L.J.3
Lucey, C.A.4
Wang, L.5
Mason, L.6
Login, G.7
Ymamkawa, M.8
Moses, G.9
Bouchard, P.10
Hayes, L.L.11
Bedrosian, C.12
Dorner, A.J.13
-
9
-
-
34447303546
-
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy - and radiotherapy-induced mucositis
-
10.1093/annonc/mdl332, 17030544
-
Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy - and radiotherapy-induced mucositis. Ann Oncol 2007, 18:817-826. 10.1093/annonc/mdl332, 17030544.
-
(2007)
Ann Oncol
, vol.18
, pp. 817-826
-
-
Blijlevens, N.1
Sonis, S.2
-
10
-
-
0036907234
-
Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats
-
10.1023/A:1021061306913, 12498296
-
Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci 2002, 47:2751-2757. 10.1023/A:1021061306913, 12498296.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 2751-2757
-
-
Gibson, R.J.1
Keefe, D.M.2
Thompson, F.M.3
Clarke, J.M.4
Goland, G.J.5
Cummins, A.G.6
-
11
-
-
33746072661
-
Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis
-
10.1007/s00520-006-0052-7, 16775647
-
von Bultzingslowen I, Brennan MT, Spijkervet FK, Logan R, Stringer A, Raber-Durlacher JE, Keefe D. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer 2006, 14:519-527. 10.1007/s00520-006-0052-7, 16775647.
-
(2006)
Support Care Cancer
, vol.14
, pp. 519-527
-
-
von Bultzingslowen, I.1
Brennan, M.T.2
Spijkervet, F.K.3
Logan, R.4
Stringer, A.5
Raber-Durlacher, J.E.6
Keefe, D.7
-
12
-
-
11144356545
-
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients
-
10.1002/cncr.20162, 15108222
-
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100:1995-2025. 10.1002/cncr.20162, 15108222.
-
(2004)
Cancer
, vol.100
, pp. 1995-2025
-
-
Sonis, S.T.1
Elting, L.S.2
Keefe, D.3
Peterson, D.E.4
Schubert, M.5
Hauer-Jensen, M.6
Bekele, B.N.7
Raber-Durlacher, J.8
Donnelly, J.P.9
Rubenstein, E.B.10
-
13
-
-
34548067110
-
A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2
-
10.1158/1535-7163.MCT-07-0113, 17699727
-
Yeoh AS, Gibson RJ, Yeoh EE, Bowen JM, Stringer AM, Giam KA, Keefe DM. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Mol Cancer Ther 2007, 6:2319-2327. 10.1158/1535-7163.MCT-07-0113, 17699727.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 2319-2327
-
-
Yeoh, A.S.1
Gibson, R.J.2
Yeoh, E.E.3
Bowen, J.M.4
Stringer, A.M.5
Giam, K.A.6
Keefe, D.M.7
-
14
-
-
0034333042
-
Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy
-
Hovdenak N, Fajardo LF, Hauer-Jensen M. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiation Oncology Biol Phys 2000, 48(4):1111-1117.
-
(2000)
Int J Radiation Oncology Biol Phys
, vol.48
, Issue.4
, pp. 1111-1117
-
-
Hovdenak, N.1
Fajardo, L.F.2
Hauer-Jensen, M.3
-
15
-
-
67349148295
-
Irinotecan-induced mucositis is associated with changes in intestinal mucins
-
10.1007/s00280-008-0855-y, 18998135
-
Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh ASJ, Laurence J, Keefe DMK. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol 2009, 64(1):123-132. 10.1007/s00280-008-0855-y, 18998135.
-
(2009)
Cancer Chemother Pharmacol
, vol.64
, Issue.1
, pp. 123-132
-
-
Stringer, A.M.1
Gibson, R.J.2
Logan, R.M.3
Bowen, J.M.4
Yeoh, A.S.J.5
Laurence, J.6
Keefe, D.M.K.7
-
16
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
-
10.1006/meth.2001.1262, 11846609
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
17
-
-
27744593919
-
Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes
-
10.1016/j.ijrobp.2005.04.041, 16099597
-
Yeoh AS, Bowen JM, Gibson RJ, Keefe DM. Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol Phys 2005, 63:1295-1303. 10.1016/j.ijrobp.2005.04.041, 16099597.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.63
, pp. 1295-1303
-
-
Yeoh, A.S.1
Bowen, J.M.2
Gibson, R.J.3
Keefe, D.M.4
-
18
-
-
0032977747
-
Radiobiological mechanisms of anti-inflammatory radiotherapy
-
10.1016/S0167-8140(99)00066-3, 10435813
-
Trott KR, Kamprad F. Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother Oncol 1999, 51:197-203. 10.1016/S0167-8140(99)00066-3, 10435813.
-
(1999)
Radiother Oncol
, vol.51
, pp. 197-203
-
-
Trott, K.R.1
Kamprad, F.2
-
19
-
-
0141757460
-
MAPK pathways in radiation responses
-
10.1038/sj.onc.1206701, 12947395
-
Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003, 22(37):5885-5896. 10.1038/sj.onc.1206701, 12947395.
-
(2003)
Oncogene
, vol.22
, Issue.37
, pp. 5885-5896
-
-
Dent, P.1
Yacoub, A.2
Fisher, P.B.3
Hagan, M.P.4
Grant, S.5
-
20
-
-
33645983982
-
The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease
-
Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knbb JR, Dean K, Franzoso G. The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Diff 2006, 13:712-729.
-
(2006)
Cell Death Diff
, vol.13
, pp. 712-729
-
-
Papa, S.1
Bubici, C.2
Zazzeroni, F.3
Pham, C.G.4
Kuntzen, C.5
Knbb, J.R.6
Dean, K.7
Franzoso, G.8
-
22
-
-
17644385184
-
Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat
-
10.1007/s10238-004-0055-y, 15750766
-
Gibson RJ, Bowen JM, Cummins AG, Keefe DM. Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat. Clin Exp Med 2005, 4:188-195. 10.1007/s10238-004-0055-y, 15750766.
-
(2005)
Clin Exp Med
, vol.4
, pp. 188-195
-
-
Gibson, R.J.1
Bowen, J.M.2
Cummins, A.G.3
Keefe, D.M.4
-
23
-
-
0141618280
-
Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer
-
10.1046/j.1440-1746.2003.03136.x, 12911669
-
Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 2003, 18:1095-1100. 10.1046/j.1440-1746.2003.03136.x, 12911669.
-
(2003)
J Gastroenterol Hepatol
, vol.18
, pp. 1095-1100
-
-
Gibson, R.J.1
Bowen, J.M.2
Inglis, M.R.3
Cummins, A.G.4
Keefe, D.M.5
|